Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20µg and Drospirenone 3mg

Author： Cibula D.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.26, Iss.3, 2006-01, pp. : 143-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-dose ethinylestradiol/drospirenone effective oral contraceptive

By  

Inpharma, Vol. 1, Iss. 1535, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

User Satisfaction with the Combined Oral Contraceptive Drospirenone 3 mg/Ethinylestradiol 20 μg (Yasminelle®) in Clinical Practice: A Multi-Country, Questionnaire-Based Study

By Short Mary  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 153-159

Adis International

Access to resources Recommend Favorite

Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen): A Review of Its Use in Contraception, Premenstrual Dysphoric Disorder and Moderate Acne Vulgaris

By Fenton Caroline   Wellington Keri   Moen Marit D.   Robinson Dean M.  

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1749-1765

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/Drospirenone (Yasmin®) in Healthy Chinese Women: A Randomized, Open-Label, Controlled, Multicentre Trial

By Guang-Sheng Fan  

Clinical Drug Investigation, Vol. 30, Iss. 6, 2010-06 ,pp. : 387-396

Adis International

Access to resources Recommend Favorite

Added Benefits and User Satisfaction with a Low-Dose Oral Contraceptive Containing Drospirenone: Results of Three Multicentre Trials

By Bitzer Johannes  

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 73-78

Adis International

Access to resources Recommend Favorite